Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 199

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

X-linked adrenoleukodystrophy: Clinical, biochemical and pathogenetic aspects

Open access
Berger, Johannes, Gärtner, Jutta · 2006 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbamcr.2006.07.010

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 39 references

Research works printed but not linked: 85

  1. Haberfeld, 1910, Zur diffusen Hirn-Rückenmarksclerose im Kindesalter, Dtsch. Z. Nervenheilkd., 40, 436, 10.1007/BF01629013 · DOI
  2. Schilder, 1912, Zur Kentniss der sogenannten diffusen Sklerose, Z. Gesamte Neurol. Psychiatr., 10, 1, 10.1007/BF02901445 · DOI · Paper page
  3. Siemerling, 1923, Bronzekrankheit und sklerosierende Encephalomyelitis, Arch. Psychiatr Nervkrankh., 68, 217, 10.1007/BF01835678 · DOI
  4. Fanconi, 1963, Morbus Addison mit Hirnsklerose im Kindesalter: ein hereditaeres Syndrom mit X-chromosomaler Vererbung?, Helv. Paediatr. Acta, 18, 480
  5. Griffin, 1977, Adrenomyeloneuropathy: a probable variant of adrenoleukodystrophy: I. Clinical and endocrinologic aspecrs, Neurology, 27, 1107, 10.1212/WNL.27.12.1107 · DOI · Paper page
  6. Dobyns, 2004, Inheritance of most X-linked traits is not dominant or recessive, just X-linked, Am. J. Med. Genet., 129, 136, 10.1002/ajmg.a.30123 · DOI · Paper page
  7. Restuccia, 1997, Neurophysiological abnormalities in adrenoleukodystrophy carriers. Evidence of different degrees of central nervous system involvement, Brain, 120, 1139, 10.1093/brain/120.7.1139 · DOI · Paper page
  8. van Geel, 1997, X-linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy, J. Neurol. Neurosurg. Psychiatry, 63, 4, 10.1136/jnnp.63.1.4 · DOI · Paper page
  9. Migeon, 1981, Adrenoleukodystrophy: evidence for X-linkage, inactivation and selection favoring the mutant allele in heterozygous cells, Proc. Natl. Acad. Sci. U. S. A., 78, 5066, 10.1073/pnas.78.8.5066 · DOI · Paper page
  10. Oberle, 1985, The telomere of the human X-chromosom long arm: presence of a highly polymorphic DNA marker and analysis of recombination frequency, Proc. Natl. Acad. Sci. U. S. A., 82, 2824, 10.1073/pnas.82.9.2824 · doi:10.1073/pnas.82.9.2824
  11. Aubourg, 1987, Linkage of adrenoleukodystrophy to a polymorphic DNA probe, Ann. Neurol., 21, 349, 10.1002/ana.410210406 · DOI
  12. Holzinger, 1999, Full length cDNA cloning, promoter sequence and genomic organisation of the human adrenoleukodystrophy related (ALDR) gene functionally redundant to the gene responsible for X-linked adrenoleukodystrophy, Biochem. Bioph. Res. Commun., 258, 436, 10.1006/bbrc.1999.0535 · DOI
  13. Berger, 1994, X-linked adrenoleukodystrophy (ALD): a novel mutation of the ALD gene in 6 members of a family presenting with 5 different phenotypes, Biochem. Biophys. Res. Commun., 205, 1638, 10.1006/bbrc.1994.2855 · DOI · Paper page
  14. Smith, 1999, X-linked adrenoleukodystrophy: genes, mutations, and phenotypes, Neurochem. Res., 24, 521, 10.1023/A:1022535930009 · DOI · Paper page
  15. Korenke, 1996, Cerebral adrenoleukodystrophy (ALD) in only one of monozygotic twins with an identical ALD genotype, Ann. Neurol., 40, 254, 10.1002/ana.410400221 · DOI · Paper page
  16. Yatsenko, 2001, Late-onset Stargardt disease is associated with missense mutations that map outside known functional regions of ABCR (ABCA4), Hum. Genet., 108, 346, 10.1007/s004390100493 · DOI
  17. Higgins, 1992, ABC transporters. From microorganisms to man, Annu. Rev. Cell Biol., 8, 67, 10.1146/annurev.cb.08.110192.000435 · DOI · Paper page
  18. Lombard-Platet, 1996, A close relative of the adrenoleukodystrophy (ALD) gene codes for a peroxisomal protein with a specific expression pattern, Proc. Natl. Acad. Sci. U. S. A., 96, 1265, 10.1073/pnas.93.3.1265 · DOI · Paper page
  19. Holzinger, 1997, cDNA cloning and mRNA expression of the human adrenoleukodystrophy related protein (ALDR), a peroxisomal ABC-transporter, Biochem. Bioph. Res. Commun., 239, 261, 10.1006/bbrc.1997.7391 · DOI · Paper page
  20. Gärtner, 1992, Mutations in the 70 kDa peroxisomal membrane protein gene in Zellweger syndrome, Nat. Genet., 1, 16, 10.1038/ng0492-16 · DOI · Paper page
  21. Shani, 1997, Identification of a fourth half ABC transporter in the human peroxisomal membrane, Hum. Mol. Genet., 6, 1925, 10.1093/hmg/6.11.1925 · DOI
  22. Pollard, 1995, Localisation of mRNAs for adrenoleuko-dystrophy and the 70 kDa peroxisomal (PMP70) proteins in the rat brain during post-natal development, J. Neurosci. Res., 42, 433, 10.1002/jnr.490420318 · DOI
  23. Troffer-Charlier, 1998, Mirror expression of adrenoleukodystrophy and adrenoleukodystrophy related genes in mouse tissues and human cell lines, Eur. J. Cell Biol., 75, 254, 10.1016/S0171-9335(98)80121-0 · DOI · Paper page
  24. Liu, 1999, Homo- and heterodimerization of peroxisomal ATP-binding cassette half-transporters, J. Biol. Chem., 274, 32738, 10.1074/jbc.274.46.32738 · DOI · Paper page
  25. Tanaka, 2002, ATP binding/hydrolysis by and phosphorylation of peroxiosmal ATP-binding cassette proteins PMP70 (ABCD3) and adrenoleukodystrophy protein (ABCD1), J. Biol. Chem., 277, 40142, 10.1074/jbc.M205079200 · DOI
  26. Guimaraes, 2004, Mouse liver PMP70 and ALDP: omomeric interactions prevail in vivo, Biochem. Biophys. Acta, 1689, 235
  27. Watkins, 1995, Altered expression of ALDP in X-linked adrenoleukodystrophy, Am. J. Hum. Genet., 57, 292
  28. Kammerer, 1998, Cloning and characterization of the gene encoding the human peroxisomal assembly protein Pex3p, FEBS Lett., 429, 53, 10.1016/S0014-5793(98)00557-2 · DOI
  29. Lazo, 1988, Peroxisomal lignoceroyl-CoA ligase deficiency in childhood adrenoleukodystrophy and adrenomyeloneuropathy, Proc. Natl. Acad. Sci. U. S. A., 85, 7647, 10.1073/pnas.85.20.7647 · DOI · Paper page
  30. Wanders, 1988, Direct evidence that the deficient oxidation of very long chain fatty acids in X-linked adrenoleukodystrophy is due to an impaired ability of peroxisomes to activate very long chain fatty acids, Biochem. Bioph. Res. Commun., 153, 618, 10.1016/S0006-291X(88)81140-9 · DOI · Paper page
  31. Uchiyama, 1996, Molecular cloning of cDNA encoding rat very long-chain Acyl-CoA synthetase, J. Biol. Chem., 271, 30360, 10.1074/jbc.271.48.30360 · DOI · Paper page
  32. Berger, 1998, cDNA cloning and mRNA distribution of a mouse very long-chain Acyl-CoA synthetase, FEBS Lett., 425, 305, 10.1016/S0014-5793(98)00255-5 · DOI
  33. Steinberg, 1999, Human very-long-chain acyl-CoA synthetase: cloning, topography, and relevance to branched-chain fatty acid metabolism, Biochem. Biophys. Res. Commun., 257, 615, 10.1006/bbrc.1999.0510 · DOI
  34. Heinzer, 2002, Mouse very long-chain acyl-CoA synthetase in X-linked adrenoleukodystrophy, J. Biol. Chem., 277, 28765, 10.1074/jbc.M203053200 · DOI
  35. Berger, 1998, A novel relative of the very-long-chain acyl-CoA synthetase and fatty acid transporter protein gene with a distinct expression pattern, Biochem. Biophys. Res. Commun., 247, 255, 10.1006/bbrc.1998.8770 · DOI
  36. Hirsch, 1998, A family of fatty acid transporters conserved from mycobacterium to man, Proc. Natl. Acad. Sci. U. S. A., 95, 8625, 10.1073/pnas.95.15.8625 · DOI · Paper page
  37. Pei, 2004, Mouse very long-chain Acyl-CoA synthetase 3/fatty acid transport protein 3 catalyzes fatty acid activation but not fatty acid transport in MA-10 cells, J. Biol. Chem., 279, 54454, 10.1074/jbc.M410091200 · DOI
  38. Fraisl, 2006, A novel mammalian Bubblegum-related acyl-CoA synthetase restricted to testes and possibly involved in spermatogenesis, Arch. Biochem. Biophys., 451, 23, 10.1016/j.abb.2006.04.013 · DOI
  39. Min, 1999, Preventing neurodegeneration in the Drosophila mutant bubblegum, Science, 284, 1985, 10.1126/science.284.5422.1985 · DOI · Paper page
  40. Steinberg, 2000, Very long-chain acyl-CoA synthetases. Human “bubblegum” represents a new family of proteins capable of activating very long-chain fatty acids, J. Biol. Chem., 275, 35162, 10.1074/jbc.M006403200 · DOI
  41. Moriya-Sato, 2000, Novel acyl-CoA synthetase in adrenoleukodystrophy target tissues, Biochem. Biophys. Res. Commun., 279, 62, 10.1006/bbrc.2000.3897 · DOI
  42. Tang, 2001, Cloning and characterization of a hormonally regulated rat long chain acyl-CoA synthetase, Proc. Natl. Acad Sci. U. S. A., 98, 6581, 10.1073/pnas.121046998 · doi:10.1073/pnas.121046998
  43. Pei, 2003, The acyl-CoA synthetase “Bubblegum” (Lipidosin), J. Biol. Chem., 278, 47070, 10.1074/jbc.M310075200 · DOI
  44. Fraisl, 2004, Murine bubblegum orthologue is a microsomal very long-chain acyl-CoA synthetase, Biochem. J., 377, 85, 10.1042/bj20031062 · DOI
  45. Oezen, 2005, Accumulation of very long-chain fatty acids does not affect mitochondrial function in adrenoleukodystrophy protein deficiency, Hum. Mol. Genet., 14, 1127, 10.1093/hmg/ddi125 · DOI
  46. Heinzer, 2003, A very long-chain acyl-CoA synthetase-deficient mouse and its relevance to X-linked adrenoleukodystrophy, Hum. Mol. Genet., 12, 1145, 10.1093/hmg/ddg126 · DOI
  47. Brown, 1982, Adrenoleukodystrophy: effects of dietary restriction of very long chain fatty acids and of administration of carnitine and clofibrate on clinical status and plasma fatty acids, Johns Hopkins Med. J., 151, 164
  48. Tsuji, 1984, Fatty acid elongation activity in fibroblasts from patients with adrenoleukodystrophy (ALD), J. Biochem., 96, 1241, 10.1093/oxfordjournals.jbchem.a134942 · DOI
  49. Koike, 1991, Physiological significance of fatty acid elongation system in adrenoleukodystrophy, J. Neurol. Sci., 103, 188, 10.1016/0022-510X(91)90163-2 · DOI
  50. Kemp, 2005, Elongatin of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy, Mol. Gen. Metabol., 84, 144, 10.1016/j.ymgme.2004.09.015 · DOI · Paper page
  51. Weinhofer, 2005, X-linked adrenoleukodystrophy mice demonstrate abnormalities in cholesterol metabolism, FEBS Lett., 579, 5512, 10.1016/j.febslet.2005.09.014 · DOI
  52. Powers, 1985, Adrenoleukodystrophy (Adreno-testiculo-leuko-myelo-neuropathic-complex), Clin. Neuropathol., 4, 181
  53. Powers, 2000, Adrenomyeloneuropathy: a neuropathologic review featuring its noninflammatory myelopathy, J. Neuropathol. Exp. Neurol., 59, 89, 10.1093/jnen/59.2.89 · DOI · Paper page
  54. Powers, 2001, Dorsal root ganglia in adrenomyeloneuropathy: neuronal atrophy and abnormal mitochondria, J. Neuropathol. Exp. Neurol., 60, 493, 10.1093/jnen/60.5.493 · DOI · Paper page
  55. Powers, 1982, Fetal adrenoleukodystrophy: the significance of pathologic lesions in adrenal gland and testis, Hum. Pathol., 13, 1013, 10.1016/S0046-8177(82)80093-2 · DOI · Paper page
  56. Powers, 1980, A correlative study of the adrenal cortex in adreno-leukodystrophy: evidence for a fatal intoxication with very long chain saturated fatty acids, Invest. Cell Pathol., 3, 353
  57. Powers, 1981, The testis in adrenoleukodystrophy, Am. J. Pathol., 102, 90
  58. Smith, 1991, A genetic basis for the multiple phenotypes of X-linked adrenoleukodystrophy, Am. J. Hum. Genet., 49, 165
  59. Maestri, 1992, Predictions of a 2-locus model for disease heterogeneity: applications to adrenoleukodystrophy, Am. J. Hum. Genet., 44, 576, 10.1002/ajmg.1320440509 · DOI
  60. Forss-Petter, 1997, Accumulation of very long chain fatty acids in mice with a targeted inactivation of the X-linked adrenoleukodystrophy gene, J. Neurosci. Res., 50, 829, 10.1002/(SICI)1097-4547(19971201)50:5<829::AID-JNR19>3.0.CO;2-W · doi:10.1002/(sici)1097-4547(19971201)50:5<829::aid-jnr19>3.0.co;2-w
  61. Cartier, 2000, Simvastatin does not normalize very long chain fatty acids in adrenoleukodystrophy mice, FEBS Lett., 478, 205, 10.1016/S0014-5793(00)01852-4 · DOI
  62. Netik, 2000, Rolipram does not normalize very long-chain fatty acid levels in adrenoleukodystrophy protein-deficient fibroblasts and mice, J. Inherited Metab. Dis., 23, 615, 10.1023/A:1005686114356 · DOI
  63. Yamada, 2000, Lovastatin does not correct the accumulation of very long-chain fatty acids in tissues of adrenoleukodystrophy protein-deficient mice, J. Inherited Metab. Dis., 23, 607, 10.1023/A:1005634130286 · DOI
  64. Powers, 2005, Adreno-leukodystrophy: oxidative stress of mice and men, J. Neuropathol. Exp. Neurol., 64, 1067, 10.1097/01.jnen.0000190064.28559.a4 · DOI
  65. Shani, 1995, PXA1, a possible Saccharomyces cerevisiae ortholog of the human adrenoleukodystrophy gene, Proc. Natl. Acad. Sci. U. S. A., 92, 6012, 10.1073/pnas.92.13.6012 · DOI · Paper page
  66. Swartzman, 1996, The PAL1 gene product is a peroxisomal ATP-binding cassette transporter in the yeast Saccharomyces cerevisiae, J. Cell Biol., 132, 549, 10.1083/jcb.132.4.549 · DOI
  67. Hettema, 1996, The ABC transporter proteins Pat1 and Pat2 are required for import of long-chain fatty acids into peroxisomes of Saccharomyces cerevisiae, EMBO J., 15, 3813, 10.1002/j.1460-2075.1996.tb00755.x · DOI · Paper page
  68. Verleur, 1997, Transport of activated fatty acids by the peroxisomal ATP-binding-cassette transporter Pxa2 in a semi-intact yeast cell system, Eur. J. Biochem., 249, 657, 10.1111/j.1432-1033.1997.00657.x · DOI · Paper page
  69. Rizzo, 1986, Adrenoleukodystrophy: oleic acid lowers fibroblast C22-26 fatty acids, Neurology, 36, 357, 10.1212/WNL.36.3.357 · DOI
  70. Asano, 1994, Effects of erucic acid therapy on Japanese patients with X-linked adrenoleukodystrophy, Brain Dev., 16, 454, 10.1016/0387-7604(94)90007-8 · DOI
  71. Rasmussen, 1994, Brain, liver, and adipose tissue erucic and very long chain fatty acid levels in adrenoleukodystrophy patients treated with glyceryl trierucate and trioleate oils (Lorenzo's oil), Neurochem. Res., 19, 1073, 10.1007/BF00968719 · DOI
  72. Korenke, 1995, Glyceroltrioleate/glyceroltrierucate therapy in 16 patients with X-chromosomal adrenoleukodystrophy/adrenomyeloneuropathy: effect on clinical, biochemical and neurophysiological parameters, Eur. J. Pediatr., 154, 64, 10.1007/BF01972976 · DOI
  73. van Geel, 1999, Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with “Lorenzo'soil”, J. Neurol., Neurosurg. Psychiatry, 67, 290, 10.1136/jnnp.67.3.290 · DOI · Paper page
  74. Korenke, 1997, Progression of X-linked adrenoleukodystrophy under interferon-ß therapy, J. Inherited Metab. Dis., 20, 59, 10.1023/A:1005361607523 · DOI
  75. Krivit, 1995, The future for treatment by bone marrow transplantation for adrenoleukodystrophy, metachromatic leukodystrophy, globoid cell leukodystrophy and Hurler syndrome, J. Inherited Metab. Dis., 18, 398, 10.1007/BF00710052 · DOI · Paper page
  76. Peters, 2004, Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999, Blood, 104, 881, 10.1182/blood-2003-10-3402 · DOI · Paper page
  77. Cartier, 1995, Retroviral-mediated gene transfer corrects very-long-chain fatty acid metabolism in adrenoleukodystrophy fibroblasts, Proc. Natl. Acad. Sci. U. S. A., 92, 1674, 10.1073/pnas.92.5.1674 · DOI · Paper page
  78. Weinhofer, 2002, Cholesterol regulates ABCD2 expression: Implication for therapy of X-linked adrenoleukodystrophy, Hum. Mol. Genet., 11, 2701, 10.1093/hmg/11.22.2701 · DOI · Paper page
  79. Singh, 1998, Lovastatin and sodium phenylacetate normalize the levels of very long chain fatty acids in skin fibroblasts of X-adrenoleukodystrophy, FEBS Lett., 426, 342, 10.1016/S0014-5793(98)00370-6 · DOI
  80. Pai, 2000, Lovastatin therapy for X-linked adrenoleukodystrophy: Clinical and biochemical observations on 12 patients, Mol. Genet. Metab., 69, 312, 10.1006/mgme.2000.2977 · DOI
  81. Singh, 1998, Lovastatin for X-linked adrenoleukodystrophy, N. Engl. J. Med., 339, 702, 10.1056/NEJM199809033391012 · DOI
  82. Yamada, 2000, Lovastatin does not correct the accumulation of very long-chain fatty acids in tissues of adrenoleukodystrophy protein-deficient mice, J. Inherited Metab. Dis., 23, 607, 10.1023/A:1005634130286 · DOI
  83. Weinhofer, 2005, LXRalpha interferes with SREBP1c-mediated Abcd2 expression: novel cross-talk in gene regulation, J. Biol. Chem., 280, 41243, 10.1074/jbc.M509450200 · DOI
  84. Rampler, 2003, Evaluation of the therapeutic potential of PPAR alpha agonists for X-linked adrenoleukodystrophy, Mol. Genet. Metab., 80, 398, 10.1016/j.ymgme.2003.09.002 · DOI
  85. Fourcade, 2003, Thyroid hormone induction of the drenoleukodystrophy-related gene (ABCD2), Mol. Pharmacol., 63, 1296, 10.1124/mol.63.6.1296 · DOI

Cited by

Metadata

Authors
Berger, J., & Gärtner, J.
Venue
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Publisher
Elsevier BV
Published
2006-12
Volume
1763
Issue
12
Pages
1721-1732
ISSN
0167-4889 (ISSN-L)
OpenAlex
W2138312139
Cited by
199
References
39
FWCI
6.79
Type
journal article
Language
en
Open access
bronze
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.